CompaniesEpiTherapeutics

EpiTherapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

649

By Status

WITHDRAWN: 2TERMINATED: 2COMPLETED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
Today
NCT03480659
NCT03494803
NCT03499678
NCT03483922
NCT03734419
Hover over trial bars to see details

Recent Trials

NCT03734419Lead Sponsor
The Use of Aging Biomarkers in Saliva, Based on DNA Methylation Status in Elovl2 to Predict Biological Age
N/AWithdrawn
Started: Dec 1, 2019 · Completed: Dec 1, 2021
NCT03483922Lead Sponsor
HCC Screening Using DNA Methylation Changes in ctDNA
N/ACompleted
403 participants
Started: Aug 20, 2018 · Completed: Nov 1, 2020
NCT03499678Lead Sponsor
Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA
N/ATerminated
81 participants
Started: Jul 1, 2018 · Completed: Jul 19, 2019
NCT03480659Lead Sponsor
Detection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC
N/ATerminated
165 participants
Started: Jun 1, 2018 · Completed: Sep 1, 2021
NCT03494803Lead Sponsor
Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC
N/AWithdrawn
Started: Jun 1, 2018 · Completed: Dec 1, 2021